Literature DB >> 10466588

The electroretinogram in diabetic retinopathy.

R Tzekov1, G B Arden.   

Abstract

Electroretinography (ERG) is an objective method of evaluating retinal function. Since its introduction to clinical practice in the 1940s, it has become a useful and routine diagnostic clinical tool in ophthalmology. This review summarizes the role of ERG as a clinical technique for evaluating the progression of diabetic retinopathy and as a research tool for increasing our understanding of the pathophysiology of diabetic retinopathy. Most studies show unequivocally that the different types of ERG tests detect local abnormalities or widespread pathology, even in very early stages of the disease. It seems plausible that measurements from ERG recordings, particularly the oscillatory potentials, may be useful for predicting progression from nonproliferative to the more sight-threatening stages--preproliferative or proliferative--of diabetic retinopathy. Some recent work implies that the ERG can also be a useful diagnostic method for discriminating between eyes with diabetic retinopathy and those without the condition.

Entities:  

Mesh:

Year:  1999        PMID: 10466588     DOI: 10.1016/s0039-6257(99)00063-6

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  88 in total

Review 1.  The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment.

Authors:  G B Arden
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

2.  Extraction and modeling of the Oscillatory Potential: signal conditioning to obtain minimally corrupted Oscillatory Potentials.

Authors:  Peter H Derr; Andrew U Meyer; Edward J Haupt; Mitchell G Brigell
Journal:  Doc Ophthalmol       Date:  2002-01       Impact factor: 2.379

3.  Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes.

Authors:  Wendy W Harrison; Marcus A Bearse; Jason S Ng; Nicholas P Jewell; Shirin Barez; Dennis Burger; Marilyn E Schneck; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-09       Impact factor: 4.799

4.  Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy.

Authors:  André Messias; José Afonso Ramos Filho; Katharina Messias; Felipe P P Almeida; Rogério A Costa; Ingrid U Scott; Florian Gekeler; Rodrigo Jorge
Journal:  Doc Ophthalmol       Date:  2012-03-29       Impact factor: 2.379

5.  Signal processing techniques for oscillatory potential extraction in the electroretinogram: automated highpass cutoff frequency estimation.

Authors:  John Meklenburg; Edward A Clancy; Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2012-07-10       Impact factor: 2.379

Review 6.  Retinal Failure in Diabetes: a Feature of Retinal Sensory Neuropathy.

Authors:  Ellyn J Gray; Thomas W Gardner
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

7.  Full-field ERG in diabetic retinopathy: a screening tool?

Authors:  Radouil Tzekov
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-09       Impact factor: 3.117

8.  Cone Photoreceptor Dysfunction in Early-Stage Diabetic Retinopathy: Association Between the Activation Phase of Cone Phototransduction and the Flicker Electroretinogram.

Authors:  J Jason McAnany; Jason C Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-01-02       Impact factor: 4.799

9.  Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats.

Authors:  P Sicard; N Acar; S Grégoire; B Lauzier; A M Bron; C Creuzot-Garcher; L Bretillon; C Vergely; L Rochette
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

Review 10.  Retinal ganglion cells in diabetes.

Authors:  Timothy S Kern; Alistair J Barber
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.